Development of a therapeutic vaccine targeting Merkel cell polyomavirus capsid protein VP1 against Merkel cell carcinoma
出版年份 2021 全文链接
标题
Development of a therapeutic vaccine targeting Merkel cell polyomavirus capsid protein VP1 against Merkel cell carcinoma
作者
关键词
-
出版物
npj Vaccines
Volume 6, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-10-05
DOI
10.1038/s41541-021-00382-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evaluation of Merkel Cell Polyomavirus DNA in Tissue Samples from Italian Patients with Diagnosis of MCC
- (2021) Carla Prezioso et al. Viruses-Basel
- Merkel Cell Carcinoma: New Trends
- (2021) Ellen M. Zwijnenburg et al. Cancers
- Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development
- (2020) Shira Tabachnick-Cherny et al. MOLECULAR CARCINOGENESIS
- Merkel Cell Polyomavirus and Merkel Cell Carcinoma
- (2020) Valeria Pietropaolo et al. Cancers
- A “hit-and-run” affair – A possible link for cancer progression in virally driven cancers
- (2020) Danyelle A. Ferreira et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo
- (2019) Yang Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Merkel Cell Carcinoma
- (2019) Christine Cornejo et al. DERMATOLOGIC CLINICS
- Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
- (2018) Christopher K. Bichakjian et al. Journal of the National Comprehensive Cancer Network
- Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues
- (2018) Anchalee Tantiwetrueangdet et al. MEDICAL ONCOLOGY
- Clearance of HBeAg and HBsAg of HBV in mice model by a recombinant HBV vaccine combined with GM-CSF and IFN-α as an effective therapeutic vaccine adjuvant
- (2018) Weidong Zhao et al. Oncotarget
- CD4 + T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness
- (2017) Tomasz Ahrends et al. IMMUNITY
- Merkel cell carcinoma
- (2017) Jürgen C. Becker et al. Nature Reviews Disease Primers
- Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma
- (2016) M. Samimi et al. BRITISH JOURNAL OF DERMATOLOGY
- CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model
- (2016) Marie Jordan et al. CANCER LETTERS
- Vaccine adjuvants as potential cancer immunotherapeutics
- (2016) Burcu Temizoz et al. INTERNATIONAL IMMUNOLOGY
- Phylogenetic and structural analysis of merkel cell polyomavirus VP1 in Brazilian samples
- (2016) Camila F. Baez et al. VIRUS RESEARCH
- CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma
- (2014) Britnie R. James et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors
- (2014) R. Lyngaa et al. CLINICAL CANCER RESEARCH
- The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
- (2013) John P Vasilakos et al. Expert Review of Vaccines
- Merkel cell polyomavirus infection occurs during early childhood and is transmitted between siblings
- (2013) Claire Martel-Jantin et al. JOURNAL OF CLINICAL VIROLOGY
- Phylogenetic analysis of Merkel cell polyomavirus based on full-length LT and VP1 gene sequences derived from neoplastic tumours in Japanese patients
- (2013) Y. Hashida et al. JOURNAL OF GENERAL VIROLOGY
- Creation of a Merkel cell polyomavirus small T antigen-expressing murine tumor model and a DNA vaccine targeting small T antigen
- (2013) Bianca Gomez et al. Cell and Bioscience
- The Merkel Cell Polyomavirus Minor Capsid Protein
- (2013) Rachel M. Schowalter et al. PLoS Pathogens
- Structures of Merkel Cell Polyomavirus VP1 Complexes Define a Sialic Acid Binding Site Required for Infection
- (2012) Ursula Neu et al. PLoS Pathogens
- Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood
- (2011) J. G. Iyer et al. CLINICAL CANCER RESEARCH
- High Levels of Antibodies Against Merkel Cell Polyomavirus Identify a Subset of Patients With Merkel Cell Carcinoma With Better Clinical Outcome
- (2011) Antoine Touzé et al. JOURNAL OF CLINICAL ONCOLOGY
- Merkel Cell Carcinoma and Merkel Cell Polyomavirus: Evidence for Hit-and-Run Oncogenesis
- (2011) Roland Houben et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- T-helper Cell-Mediated Proliferation and Cytokine Responses against Recombinant Merkel Cell Polyomavirus-Like Particles
- (2011) Arun Kumar et al. PLoS One
- Development of a DNA vaccine targeting Merkel cell polyomavirus
- (2011) Qi Zeng et al. VACCINE
- Serological evidence of Merkel cell polyomavirus primary infections in childhood
- (2010) Tingting Chen et al. JOURNAL OF CLINICAL VIROLOGY
- Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays
- (2009) Yanis L. Tolstov et al. INTERNATIONAL JOURNAL OF CANCER
- Association of Merkel Cell Polyomavirus–Specific Antibodies With Merkel Cell Carcinoma
- (2009) Joseph J. Carter et al. JNCI-Journal of the National Cancer Institute
- Ultrastructural Proof of Polyomavirus in Merkel Cell Carcinoma Tumour Cells and Its Absence in Small Cell Carcinoma of the Lung
- (2009) Charlotte T. A. H. Wetzels et al. PLoS One
- TLR7 and TLR8 as targets in cancer therapy
- (2008) M P Schön et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started